Tag Archives: MD

Mednax Inc (MD) Receives a Hold from Robert W. Baird

Robert W. Baird analyst Matthew Gillmor reiterated a Hold rating on Mednax Inc (NYSE: MD) yesterday and set a price target of $50. The company’s shares closed yesterday at $45.12. According to TipRanks.com, Gillmor is a 5-star analyst with an

Mednax Inc (MD) Gets a Hold Rating from Stifel Nicolaus

In a report released today, Chad Vanacore from Stifel Nicolaus reiterated a Hold rating on Mednax Inc (NYSE: MD), with a price target of $47. The company’s shares opened today at $42.60, close to its 52-week low of $40.56. According

The SVP, General Counsel and Secy of Mednax Inc (NYSE: MD) is Buying Shares

Today, the SVP, General Counsel and Secy of Mednax Inc (NYSE: MD), Dominic Andreano, bought shares of MD for $166.3K. Following this transaction Dominic Andreano’s holding in the company was increased by 14.62% to a total of $2.01 million. This

The CFO of Mednax Inc (NYSE: MD) is Buying Shares

Today, the CFO of Mednax Inc (NYSE: MD), Vivian Lopez-Blanco, bought shares of MD for $1.01M. Following this transaction Vivian Lopez-Blanco’s holding in the company was increased by 37.04% to a total of $5.7 million. In addition to Vivian Lopez-Blanco,

Credit Suisse Sticks to Its Hold Rating for Mednax Inc

In a report released today, A.J. Rice from Credit Suisse maintained a Hold rating on Mednax Inc (NYSE: MD), with a price target of $47. The company’s shares closed on Friday at $45.22. According to TipRanks.com, Rice is a 4-star

Mizuho Securities Keeps a Hold Rating on Mednax Inc

Mizuho Securities analyst Ann Hynes reiterated a Hold rating on Mednax Inc (NYSE: MD) yesterday and set a price target of $53. The company’s shares closed yesterday at $53.94. According to TipRanks.com, Hynes is a 3-star analyst with an average